Menu
GeneBe

rs1057517085

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_000049.4(ASPA):c.827_828del(p.Cys276TyrfsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

ASPA
NM_000049.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 3.18
Variant links:
Genes affected
ASPA (HGNC:756): (aspartoacylase) This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues. Mutations in this gene cause Canavan disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
SPATA22 (HGNC:30705): (spermatogenesis associated 22) Predicted to be involved in regulation of meiotic cell cycle. Predicted to act upstream of or within several processes, including fertilization; gamete generation; and meiosis I cell cycle process. Predicted to be located in chromosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 23 pathogenic variants in the truncated region.
PP5
Variant 17-3498971-CTG-C is Pathogenic according to our data. Variant chr17-3498971-CTG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 371202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-3498971-CTG-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ASPANM_000049.4 linkuse as main transcriptc.827_828del p.Cys276TyrfsTer9 frameshift_variant 6/6 ENST00000263080.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ASPAENST00000263080.3 linkuse as main transcriptc.827_828del p.Cys276TyrfsTer9 frameshift_variant 6/61 NM_000049.4 P1
ASPAENST00000456349.6 linkuse as main transcriptc.827_828del p.Cys276TyrfsTer9 frameshift_variant 7/71 P1
SPATA22ENST00000541913.5 linkuse as main transcriptc.-74+14439_-74+14440del intron_variant 2
SPATA22ENST00000570318.1 linkuse as main transcriptc.-74+14638_-74+14639del intron_variant 2

Frequencies

GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spongy degeneration of central nervous system Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingCounsylJul 26, 2016- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 11, 2021For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Ala305 amino acid residue in ASPA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8023850, 22850825, 10909858, 16217711, 22750302, 8023850). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has been observed in individual(s) with Canavan disease (PMID: 7668285). This variant is also known as 827delGT in the literature. ClinVar contains an entry for this variant (Variation ID: 371202). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Cys276Tyrfs*9) in the ASPA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 38 amino acid(s) of the ASPA protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1057517085; hg19: chr17-3402265; API